.png)
- A2A Pharma
A2A / Daewoong Pharmaceutical Oncology Agreement
A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology Drug Discovery.
LEARN MORE
65 views
Search
Recent Posts
See AllDr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE
A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer LEARN MORE
A2A pharmaceuticals announces fourth quarter and year end results; provides business update LEARN MORE